STACS DNA

Fairfax, United States Founded: 2005 • Age: 21 yrs Acquired By InVita Healthcare Technologies
Digital supply chains and sample tracking tool for hospitals

About STACS DNA

STACS DNA is a Healthcare company based in Fairfax (United States) founded in 2005, and was acquired by InVita Healthcare Technologies in May 2021. STACS DNA offers products and services including STACS Casework, HemaConnect, iTransplant, and UDITracker. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management. Its competitors include Ovation, DDC Paternity Tests and Labvantage; 1 of its 3 listed competitors has raised funding.

Company details

Digital supply chains and sample tracking tool for hospitals. Products include STACS Sample Tracking and Control Software, STACS-CW Family of Solutions for Forensic DNA Casework Laboratories, STACS-DB Enterprise for Forensic DNA Database Laboratories, STACS-PM for Personalized Medicine Laboratories, and track Kit- a solution to trace samples and kits through their entire life cycle in the lab.

Products & Services of STACS DNA

STACS DNA offers a comprehensive portfolio of products and services, including STACS Casework, HemaConnect, iTransplant, and UDITracker.

STACS Casework
Forensic Software

Tracks forensic DNA cases and investigations efficiently.

HemaConnect
Blood Management

Manages blood and plasma sample processing securely.

iTransplant
Donation Management

Handles organ and tissue donation tracking systems.

UDITracker
Implant Management

Monitors implant lifecycles and warranties accurately.

Investors in STACS DNA

STACS DNA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include InVita Healthcare Technologies.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Specialized software solutions are provided for regulated healthcare industries.
2016invitahealth.comBaltimore, United States
Premium access

Investor details for STACS DNA

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of STACS DNA

2 dated milestones of STACS DNA across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded STACS DNA is founded.
  2. Exit Acquired by InVita Healthcare Technologies.

Competitors of STACS DNA

STACS DNA has 3 listed competitors in our database, 1 of them funded. They include Ovation, DDC Paternity Tests and Labvantage.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ovation.io2009Cambridge, United States$33.28M35
Cloud-based platform for laboratory data management and collaboration is provided.
dnacenter.com1995Fairfield, United States
DNA tests and personalized diagnostics are provided for various specialties.
labvantage.com1989Somerset, United States100
LIMS, Quality ELN and Business Intelligence solutions for laboratory
Premium access

Detailed competitors of STACS DNA

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as STACS DNA (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Stacs Dna

Premium access

Complete news archive for STACS DNA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about STACS DNA

STACS DNA was founded in 2005.

STACS DNA is headquartered in Fairfax, United States. It is registered at Fairfax, Virginia, United States.

Digital supply chains and sample tracking tool for hospitals. Products include STACS Sample Tracking and Control Software, STACS-CW Family of Solutions for Forensic DNA Casework Laboratories, STACS-DB Enterprise for Forensic DNA Database Laboratories, STACS-PM for Personalized Medicine Laboratories, and track Kit- a solution to trace samples and kits through their entire life cycle in the lab.

STACS DNA's top competitors include Ovation, DDC Paternity Tests and Labvantage.

STACS DNA offers STACS Casework, HemaConnect, iTransplant, and UDITracker.

STACS DNA has 1 investor. Key investors include InVita Healthcare Technologies.

Yes. STACS DNA was acquired by InVita Healthcare Technologies in May 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available